Concepedia

Peter O’Brien

PO

Statistics

Publications

138

Citations

7K

H-Index

44

Active since

1995

Affiliations

University of York(Current)

AstraZeneca (United Kingdom)

GlaxoSmithKline (United Kingdom)

Peter O’Brien is an author at University of York specializing in chemistry, natural sciences, and organic chemistry.

ORCID

Publications per year

1995–2023

138

Publications

138

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease

A. Douangamath, D. Fearon, Paul Gehrtz et al. · Nature Communications · 2020 · 541 citations · Full text

, , +15

Sharpless Asymmetric Aminohydroxylation: Scope, Limitations, and Use in Synthesis

Peter O’Brien · Angewandte Chemie International Edition · 1999 · 318 citations

, , +11

A Readily-Accessible (+)-Sparteine Surrogate

Michael J. Dearden, Catherine R. Firkin, Jean‐Paul R. Hermet et al. · Journal of the American Chemical Society · 2002 · 244 citations

, , +3

Recent advances in asymmetric synthesis using chiral lithium amide bases

Peter O’Brien · Journal of the Chemical Society Perkin Transactions 1 · 1998 · 240 citations

, , +4

Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking

M. Schuller, G.J. Correy, Stefan Gahbauer et al. · Science Advances · 2021 · 208 citations · Full text

, , +17

1–5 of 138